icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
 
 
 
Multiple-Dose Treatment With Ritonavir Increases the Exposure of Doravirine
 
 
  Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle WA
 
CROI: Doravirine in Non-Inferior To Darunavir+Ritonavir in Phase 3 Treatment-Naive Trial at Week 48 - (02/16/17)
 
Khalilieh SG1; Anderson MS1; Laethem T2; Yee KL1; Sanchez RI1; Fan L1; Sura M1; Van Bortel L3; Van Lancker G3; Iwamoto M1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2MSD Europe, Brussels, Belgium; 3Drug Research Unit Ghent, Ghent University Hospital, Ghent, Belgium

0329171

0329172

0329173

0329174

0329175

0329176